Little is known about the pathogenesis of the Dengue virus, a mosquito-borne
flavivirus that causes about 50 million human infections annually, some of
which may be fatal. Recent studies have demonstrated two subsets of dendritic
cells, monocyte-derived dendritic cells and human skin Langerhans cells, that
are targets for Dengue virus infection (pages
816−820).